依普利酮与氯沙坦治疗高血压哪个好
(Inspra) is used to treat hypertension and left ventricular dysfunction after acute myocardial infarction. It can effectively lower blood pressure, improve cardiac function, and reduce myocardial damage. Losartan is the first antihypertensive drug in the angiotensin II receptor antagonist (AIIA) class. Cozaia blocks angiotensin II, a key hormone in the body that regulates blood pressure.
Which is better, eplerenone or losartan, for the treatment of hypertension? Patients should choose appropriate drugs for treatment based on their physical condition and disease stage.
Without damaging the organs, eplerenone has a protective effect on the liver, heart disease, and kidneys. Not only that, it can also promote urination without losing potassium. Eplerenone also has a good antihypertensive effect on simple systolic hypertension and has a good antihypertensive effect on diet-induced obesity-related hypertension. In addition, eplerenone can significantly reduce the ultrafiltration effect of glomeruli and reduce albuminuria in patients with hypertension. This renal protective effect is more obvious for hypertensive patients with diabetes.
Patients should be aware of the following when being treated with eplerenone:
Hyperkalemia may occur with the use of eplerenone, the risk of which is increased in patients with proteinuria, diabetes mellitus, renal impairment, and in patients concurrently taking angiotensin II inhibitors, angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs, or moderate CYP3A inhibitors. Patients need to be closely monitored during treatment.
Treatment with eplerenone should be used with caution in patients with diabetes and post-myocardial infarction heart failure (especially those with proteinuria), which may increase the risk of hyperkalemia.
Patients who are allergic to any of the components of eplerenone should not be treated with this medicine.
The above is the introduction about (eplerenone), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.
Recommended related hot articles: /newsDetail/79941.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)